Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Pronorvistaon Nov 07, 2023 9:20am
356 Views
Post# 35721130

ATE

ATEIf between and 300k and 500k volume today , close between $ 1,10 -$ 1,20

Market By Price

Price Total Volume Value
1.020 500 $510
1.010 500 $505
1.000 10,500 $10,500
0.990 3,500 $3,465
0.980 3,000 $2,940
0.970 500 $485
0.960 5,500 $5,280
0.950 20,000 $19,000
0.940 6,100 $5,734
0.930 12,100 $11,253
0.930 10,000 $9,300
0.920 15,000 $13,800
0.910 3,000 $2,730
0.900 18,000 $16,200
0.890 5,000 $4,450
0.880 17,800 $15,664
0.870 15,000 $13,050
0.860 2,000 $1,720
0.850 20,500 $17,425
0.840 10,500 $8,820
 

<< Previous
Bullboard Posts
Next >>